Arsenic in Drinking Water Tied to Kidney Cancer Risk
By Lori Solomon HealthDay Reporter
THURSDAY, Dec. 19, 2024 -- Even low levels of arsenic exposure in drinking water may increase the risk for kidney cancer, according to a study published online Dec. 15 in Environmental Pollution.
Nishat Tasnim Hasan, Dr.P.H., from Texas A&M University in College Station, and colleagues assessed the association between county-level drinking water arsenic levels and kidney cancer incidences using data from 240 counties in Texas. The analysis included 28,896 cancer cases among adults aged 20 years and older and 101,776,294 person-years from 2016 to 2020.
The researchers found that when adjusting for spatial factors and covariates (e.g., demographic and socioeconomic factors and cancer risk factors such as obesity, smoking, and diabetes), there was a 6 and 22 percent higher incidence of cancer in the medium (1 to 5 ppb; relative risk, 1.06) and high arsenic (>5 ppb) group counties (relative risk, 1.22) versus low arsenic-level counties (<1 ppb), showing a dose-response relationship. When arsenic was treated as a continuous variable, the incidence increased by 4 percent for each doubling of drinking water arsenic level (relative risk, 1.04).
"This suggests that even low-level arsenic exposure in drinking water may be associated with an increased risk of kidney cancer, which aligns with previous research indicating an association between this exposure and lung, bladder, and skin cancers," coauthor Taehyun Roh, Ph.D., also from Texas A&M University, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Predialysis Nephrology Care Disparities Contribute to Vascular Access
FRIDAY, Sept. 5, 2025 -- System-based disparities in predialysis access to nephrology care contribute to disparities in the likelihood of having a mature, usable arteriovenous...
Mortality Rates From Hypertensive Renal Disease Increased From 1999 to 2023
FRIDAY, Sept. 5, 2025 -- From 1999 to 2023, there was an increase in age-adjusted mortality rates (AAMRs) for hypertensive renal disease, according to a study presented at the...
Novel Biomarker Risk Prediction Models Examined in Chronic Kidney Disease
FRIDAY, Aug. 22, 2025 -- For adults with nondialysis chronic kidney disease (CKD), risk prediction models incorporating novel biomarkers show comparable discrimination to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.